1	Cell-to-cell	cell-to-cell	_	_	_	_	_	_	_
2	contact	contact	_	_	_	_	_	_	_
3	activates	activate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	long	long	_	_	_	_	_	_	_
6	terminal	terminal	_	_	_	_	_	_	_
7	repeat	repeat	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
11	virus	virus	_	_	_	_	_	_	_
12	1	1	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	its	its	_	_	_	_	_	_	_
15	kappaB	kappab	_	_	_	_	_	_	_
16	motif	motif	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Cell-to-cell	cell-to-cell	_	_	_	_	_	_	_
2	contact	contact	_	_	_	_	_	_	_
3	between	between	_	_	_	_	_	_	_
4	peripheral	peripheral	_	_	_	_	_	_	_
5	blood	blood	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	transfected	transfecte	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	colonic	colonic	_	_	_	_	_	_	_
11	carcinoma	carcinoma	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	line	line	_	_	_	_	_	_	_
14	HT29	ht29	_	_	_	_	_	_	_
15	activates	activate	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	long	long	_	_	_	_	_	_	_
20	terminal	terminal	_	_	_	_	_	_	_
21	repeats	repeat	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	LTR	LTR	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	human	human	_	_	_	_	_	_	_
27	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
28	virus	virus	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	LTR	LTR	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	controlled	control	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	complex	complex	_	_	_	_	_	_	_
9	array	array	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	virus-encoded	virus-encoded	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	cellular	cellular	_	_	_	_	_	_	_
14	proteins	protein	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	various	various	_	_	_	_	_	_	_
3	constructs	construct	_	_	_	_	_	_	_
4	expressing	express	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	lacZ	lacz	_	_	_	_	_	_	_
7	reporter	reporter	_	_	_	_	_	_	_
8	gene	gene	_	_	_	_	_	_	_
9	under	under	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	control	control	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	intact	intact	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	three	three	_	_	_	_	_	_	_
17	deleted	delete	_	_	_	_	_	_	_
18	forms	form	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	HIV-1	HIV-1	_	_	_	_	_	_	_
21	LTR	LTR	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	we	we	_	_	_	_	_	_	_
24	obtained	obtain	_	_	_	_	_	_	_
25	evidence	evidence	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	kappaB	kappab	_	_	_	_	_	_	_
29	regulatory	regulatory	_	_	_	_	_	_	_
30	elements	element	_	_	_	_	_	_	_
31	located	located	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	U3	u3	_	_	_	_	_	_	_
35	region	region	_	_	_	_	_	_	_
36	are	be	_	_	_	_	_	_	_
37	involved	involve	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	cell-to-cell	cell-to-cell	_	_	_	_	_	_	_
40	activation	activation	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	HIV-1	HIV-1	_	_	_	_	_	_	_
43	LTR	LTR	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Cell-to-cell	cell-to-cell	_	_	_	_	_	_	_
2	contact	contact	_	_	_	_	_	_	_
3	activates	activate	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	vitro	vitro	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	kappaB	kappaB	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	p50/p65	p50/p65	_	_	_	_	_	_	_
16	heterodimer	heterodimer	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	HIV-1	HIV-1	_	_	_	_	_	_	_
20	kappaB	kappaB	_	_	_	_	_	_	_
21	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Cell-to-cell	cell-to-cell	_	_	_	_	_	_	_
2	contact	contact	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	only	only	_	_	_	_	_	_	_
8	partially	partially	_	_	_	_	_	_	_
9	inhibited	inhibit	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	100	100	_	_	_	_	_	_	_
12	microM	microm	_	_	_	_	_	_	_
13	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
14	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	correlated	correlate	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	significant	significant	_	_	_	_	_	_	_
22	decrease	decrease	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	cellular	cellular	_	_	_	_	_	_	_
25	inhibitor	inhibitor	_	_	_	_	_	_	_
26	kappaB	kappab	_	_	_	_	_	_	_
27	alpha	alpha	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	detectable	detectable	_	_	_	_	_	_	_
7	before	before	_	_	_	_	_	_	_
8	1	1	_	_	_	_	_	_	_
9	h	h	_	_	_	_	_	_	_
10	after	after	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	contact	contact	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	dependent	dependent	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	protein	protein	_	_	_	_	_	_	_
18	synthesis	synthesis	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

